01.03.2018

Gütt Olk Feldhaus advises Bright Future Pharmaceutical Laboratories Ltd. on the acquisition of Pharmazeutischen Fabrik Evers GmbH & Co. KG

Munich, March 1, 2018 – The law firm Gütt Olk Feldhaus has advised Bright Future Pharmaceutical Laboratories Ltd. on the acquisition of Pharmazeutische Fabrik Evers GmbH & Co. KG.

Bright Future Pharmaceutical Laboratories Ltd. is the largest GMP-certified pharmaceutical manufacturer in Hong Kong with production facilities in Hong Kong, China and North America.

Pharmazeutische Fabrik Evers GmbH & Co. KG is a family-owned manufacturer for pharmaceuticals and food supplements based in Pinneberg. The product portfolio consists mainly of natural remedies in the field of urology and gastroenterology. A majority of Evers' products is being exported to the Asian region.

Advisors to Bright Future Pharmaceutical Laboratories Ltd.:

  • Gütt Olk Feldhaus (Munich): Dr. Kilian Helmreich (Partner, M&A/Private Equity) and Katalin Siklosi (Associate, M&A).
  • Maiwald (Munich): Marco Stief (Partner, IP); Sebastian Haase (Associate, Pharma/Life Sciences).
  • Wagensonner Rechtsanwälte (Munich): Christopher Patt (Partner, Real Estate).

About Gütt Olk Feldhaus:

Gütt Olk Feldhaus is a Munich based law firm. The key areas of expertise of Gütt Olk Feldhaus are M&A, private equity, finance and corporate with a particular focus on transactions and cross border aspects.

Contacts:

Dr. Kilian Helmreich
Partner
Tel. +49 89 24 22 41 160
Mobile +49 177 359 85 66
Kilian.Helmreich@gof-partner.com

Press Contact

Anina Isabel Haghani
Manager Business Development, Marketing & PR

Hackenstraße 5

80331 Munich

Tel. +49 89 24 22 411-44

Anina.Haghani@gof-partner.com